COVID-19 testing service now available from MDNA's UK laboratory: Click here ›

MDNA Life Sciences’ Study Reports That Mitochondrial DNA Deletions Accurately Detect Endometriosis in Circulating Blood

MDNA Life Sciences Inc. (MDNA) announced today that the results of a recent study have been published in the journal, Biomarkers in Medicine (Biomarkers In Medicine). The study reports the evaluation of mitochondrial DNA (mtDNA) deletions detected in blood plasma as promising biomarkers for the detection of endometriosis. Based on the performance reported in the publication, biomarkers of the mitochondrial genome, discovered through MDNAs proprietary Mitomic Technologyâ„¢ platform, offer ground-breaking potential for a non-invasive test for endometriosis.